Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page
- ChecktodayChange Detected- A consolidated Locations section now lists New Jersey and New York sites, replacing the prior separate New Jersey Locations and New York Locations sections. The page revision has been updated to v3.3.3.SummaryDifference0.3%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page footer now displays 'Revision: v3.3.2' and the previous 'Revision: v3.2.0' label is removed.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page removed the general government funding/operating status notice at the top. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check36 days agoChange DetectedAdded the label 'Last Update Posted (Estimated)'. Removed the label 'Last Update Posted'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedMedlinePlus Genetics related topics: Multiple myeloma was added to the page's related topics section.SummaryDifference0.9%

- Check72 days agoChange Detected- Updated revision from v3.1.0 to v3.2.0, and added government operating-status notice and a new topic link (Multiple myeloma) for MedlinePlus Genetics. The prior revision notice was removed (v3.1.0 deleted) in favor of v3.2.0.SummaryDifference3%

Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.